NovoNorm: nā ʻōlelo aʻoaʻo no ka hoʻohana ʻana, nā analogues, nā loiloi e pili ana i ka lāʻau lapaʻau

Pin
Send
Share
Send

ʻO ka hōʻeuʻeu o ka pancreatic o kā lākou hana ponoʻī insulin e lawe i kahi mua ma ka helu ʻana i nā lāʻau antidiabetic. Ma kēia hui - hoʻomākaukau e pili ana i ka olakoleka (Maninil, Diabeton, Amaryl) a me ka pālolo.

ʻO nā lāʻau lapaʻau hou o NovoNorm, kahi loea hypoglycemic me ka hiki ke hana wikiwiki, aia nō hoʻi i ka papa hope loa. Pono e hoʻohana pono, a ʻaʻole kūpono nā papa i nā maʻi maʻi āpau me nā maʻi maʻi 2, no laila e pono e ʻike i nā kuhikuhi (ma ka liʻiliʻi loa me kona ʻano hoʻohālikelike ʻia).

Hoʻohui a me nā lāʻau lapaʻau

ʻO NovoNorma, ke kiʻi o ia ka mea i hōʻike ʻia i kēia ʻāpana, aia ka māhele o ka repaglinide, hoʻohui ʻia me ka selulosa, ka kōkaʻa palaoa, polacryline potassium, glycerin, povidone, calcium hydrogen phosphate, magnesium stearate, iron oxide, poloxamer, meglumine, dyes.

Hiki ke hoʻomaopopo ʻia ka lāʻau lapaʻau e kona ʻano (nā ʻāpana convex pōkā), ke kala (ʻāhinahina ma 1 mg a me ka brown, me kahi kiʻi pinkish i 2 mg) a me ke kiʻi a me ke ʻano o ka hui - Novo Nordisk. Hoʻopili ʻia nā papa i nā poli no 15 mau pcs.

I kahi pahu o nā papa like mai ʻelua a ʻeono paha. I Novonorm, ʻo ke kumukūʻai kekahi o nā kumukūʻai kālā loa no nā lāʻau antidiabetic: 177 rubles. no 30 papa. Hoʻokuʻu ʻia kahi lāʻau lapaʻau. Ua hoʻoholo ka mea Hana i ke ola o ka repaglinide i loko o 5 mau makahiki. ʻAʻole pono ka lāʻau lapaʻau i nā kūlana kūikawā no ka mālama.

Lapaʻau

ʻO ke kumu waihona mea repaglinide he mea hoʻoikaika i ka hana neʻe ʻana o ka hana e like me ka hemo. Ke hoʻoikaika nei i ka hana o ka pancreas, hoʻonui ka lāʻau i ka glycemia. Hoʻopili pololei nā mea hana i ka helu o nā b-cell e hiki ke hana no ka synthesis hormon.

Hoʻomaʻa ʻia ka lāʻau lapaʻau me kāna kumu mua o nā kāpena he nui o ka kāpae ʻana o ka paʻakai potassium. Hoʻololiʻi ka hoʻonāukiuki ʻana o nā ʻoi i ka hiki ke hōʻalo i nā kanalena kalaka, nā ʻoka calcium e komo ana i ka nui o ka hana o ka insulin.

Ma hope o ka lawe ʻana i ka papa papa, repaglinide i loko o ka plasma i loko o ka maʻi diabetes hōʻuluʻulu i ka hapalua hola. ʻAe kēia iā ʻoe e hoʻokipa i ka glycemia i ka wā o ka hoʻoulu ʻana a me ka hōʻiliʻili o ka meaʻai Ma ka hoʻomaka ʻana o ka ukana ma luna o ka ʻeha gastrointestinal, ke emi nei ke kaohi o ka lāʻau, hōʻemi ka nui o ka palena ma mua o 4 mau hola ma hope o ke komo ʻana o ka lāʻau lapaʻau i ka ʻeha gastrointestinal.

Ua hoʻohālikelike ka palekana o ka lāʻau lapaʻau ma kahi hoʻonohonoho kauka. Ua hōʻemi ʻia kahi helu hoʻoneʻe ʻana o ka helu glycemic indications me ka hoʻohana ʻana o 0.5-4 mg NovoNorm. Hōʻike nā hualoaʻa i ka hiki o ka preprandial (15-30 mau minuke ma mua o ka ʻai) kau ʻana o ka lāʻau.

Lapaʻau lāʻau

Hoʻomaʻi ikaika ʻo Repaglinide mai ka ʻeha gastrointestinal. ʻIke ʻia ka nui o ke koko e nānā i hoʻokahi hola ma hope o ka helu ʻana, a laila e emi iki ka wikiwiki me kahi bioavailability kūʻokoʻa o 63% me ka coefficient o ka ʻano o 11%.

ʻO ka liʻiliʻi o ka puʻuwai o ka lāʻau lapaʻau he haʻahaʻa loa (30 l), paʻa ia i nā protein plasma e like me ka manawa (a hiki i ka 98%).

Hoʻomau ʻia ka NovoNorm i nā hola 4-6 me kahi hapalua ola o kahi hola. Hoʻomau nui ka lāʻau i ka make, akā naʻe ʻaʻole ʻano o nā metabolites. Loaʻa kahi hapa waiwai o ka waiwai i lilo i loko o ka urine a me nā feces - a hiki i 8% a me 2%. Hoʻopiliʻia ka nui nui o nā metabolites me ka bile.

Ua ʻoi aʻe ka hopena o ka lāʻau i ka maʻi maʻi ma waena o nā maʻi āpau a me nā mea āpau āpau. ^ E Ha yM. Ma hope o 5 mau lā o ka lawe ʻana iā NovoNorm ma kahi o ka 3 p. / Lā. ʻO 2 mg i loko o nā hana koʻikoʻi o ka renal dysfunction AUC a me TЅ ʻelua.

ʻAʻole i komo nā maʻi o nā keiki i nā hoʻokolohua. ʻAʻole i hōʻike nā haʻawina holoholona i nā hopena teratogenic i ka repaglinide, akā ua loaʻa i nā huakui reproduction. I nā helu kiʻekiʻe o ka lāʻau lapaʻau, ʻike ʻia nā hana hoʻohālikelike o nā pēpē, ua komo pū ka lāʻau i ka waiū o ka makuahine o nā wahine.

Nā Hōʻike

Ua kuhikuhi ʻia ʻo NovoNorm no nā maʻi maʻi me ka maʻi type 2, a i ʻole ka hāʻawi ʻana o ka nohona ola ʻana i ka 100% glycemic control.

Hoʻohui ʻia ka lāʻau lapaʻau me nā lāʻau antidiabetic me kekahi ʻano hana hou - metformin, thiazolidinediones, no laila hiki ke hoʻohana pū ʻia i loko o ka hōʻola maʻi.

Nā Contraindications no Repaglinide

Hoʻohui ʻia me ka hypersensitivity i nā mea kanu o ka loiloi, ʻaʻole i hōʻike ʻia ka repaglignide:

  1. Me nā maʻi 'āpau 1 a me C-peptide maʻi maʻi maikaʻi;
  2. I loko o ka'āina o ka ketoacidosis maʻi (a me ka ʻole o ka coma);
  3. Nā makuahine hāpai a me ka lactating;
  4. ʻO ka maʻi maʻi maʻi me ka maʻi hepatic koʻikoʻi;
  5. Me ka hoʻohana ʻana i ka gemfibrozil.

Nā manaʻo e hoʻohana

Koho ke kauka i ke ʻano o ka lāʻau lapaʻau ponoʻī, i ka ʻike ʻana i nā hopena o nā hoʻokolohua, ka pūpū o ka maʻi, nā ala e like ai, a me ka pane ʻana o ke kino i ka lāʻau lapaʻau. I kēlā me kēia pule, ʻike ʻia ka hana o ka hoʻolālā i koho ʻia e hoʻomālamalama i ka ʻona, hāʻawi ʻia kahi loiloi kūlike i ka hemoglobin glycated.

Pono ke kiaʻi pono ʻana e hōʻemi i ka glycemia ma ka nui loa o ka awelika hoʻolako (ka maʻamau maʻamau) a me ka ʻike ʻana ʻole o ke ʻano kūpono o ka hopena ma hope o kekahi manawa o ka lawe ʻana i ka lāʻau (kōkuhi lua).

No NovoNorma, nā ʻōlelo aʻoi aku no ka hoʻohana ʻana i kahi wai hoʻomaka ma kahi o 0,5 mg. No ka hapalua malama e hiki iā ia ke loiloi i ka ʻano o ke kino a mālama i ka titration. Inā hoʻoneʻe ʻia ka maʻi diabetes NovoNorm mai kahi lawena hypoglycemic hou, a laila pono ka lāʻau hoʻomaka ma loko o ka 1 mg.

Hoʻokomo ka mālama mālama kino i ka hoʻohana ʻana i ka repaglinide a i ka 4 mg / lā. 15-30 mau minuke ma mua o ka papaʻaina. Pono ʻoe e inu i kahi paila ma mua o kēlā me kēiaʻai, ʻoiai ka hopena o ka lāʻau lapaʻau ma ka ʻaoʻao o ka digestive pōkole ʻoi aku ka lōʻihi. ʻO ka palena nui loa o ka lāʻau ke 16 mg / lā Ua hoʻohele ʻia nā papa i ʻelua a ʻekolu mau manawa.

Me ka mālama paʻakikī me ka metformin a i ʻole thiazolidinediones, ʻaʻole iʻoi aku ka nui o ka hopena mua o ka reaglinide i ka 0.5 mg, ua waiho ʻia ka nui o nā lāʻau lapaʻau ʻē aʻe.

ʻAʻohe mea e pili ana i ka palekana a me ka hana pono o NovoNorm no nā keiki.

ʻO nā hopena pākuʻi a me nā hemahema

No nā kumu ʻepekema, no 6 mau pule, ua hāʻawi ʻia ka repaglinide i nā mea hana ma ke ʻano he 4-20 mg / lā. i ka wa i kau ai eha. ʻO ka hypoglycemia i nā kūlana o ka hoʻokolohua i kāohi ʻia e ka ʻili o ka caloric o ka meaʻai, no laila, ʻaʻohe hopena o ka ʻaoʻao i kākau ʻia.

Inā ma ka hale kekahi mau hōʻailona o ka overdose ma ke ʻano o ka hoʻonui nui ʻana, ka haʻalulu, ka migraines a me ka nalowale o ka hoʻonohonoho ʻana, pono e hāʻawi i nā meaʻai i ka mea ʻai me ke koena o ka mea momona wikiwiki. Inā koʻikoʻi ke ʻano a nalowale nā ​​mea maʻi, ua hoʻopaʻa ʻia ʻo ia me ka glucose a hoʻouna ʻia i kahi haukapila.

ʻO ka hypoglycemia kekahi o nā ʻano nui i hiki ʻole i nā hanana hanana ʻole. ʻO ka pinepine o kona hōʻike ʻana e pili me ka ke ola o ka maʻi maʻi: kaʻai, ka pae o ka naʻau a me ka manaʻo kaumaha, ka nui a me ka kūlike i ka lāʻau. Hōʻike maʻalahi nā helu helu mau i kēia mau papa i ka papaʻaina.

Nā loea a me nā ʻōnaehanaNā ʻano hana ʻinoHeʻike
Ke ola kūloheloheallergyluhi loa
ʻO nā kaʻina hana pāhypoglycemiaʻaʻole i ʻike ʻia
Hōʻikehoʻololi hoʻololii kekahi manawa
Pūʻā naʻau a me ke kokokūlana maʻi maʻipinepine
ʻŌpala Gastrointestinalʻeha ke ʻano o ka epigastric pain, defecation rhythm disturbance, dyspeptic disorderspinepine

lawa ole

ʻIlihaaheoʻaʻole i ʻike ʻia
Hoʻomāiāate kapehu, holomoa ulu ʻanaluhi loa

Kāohi i nā hopena kūpono ʻole e hoʻolōʻihi i ka nui o ka nui o ka nui, e loaʻa i nā maʻi i hoʻopiʻi ʻia, nā maʻiʻeha, ka hoʻonaninani ʻana, ka hoʻohaʻahaʻa ʻana, me nā maʻi paʻakikī hiki ke hoʻonui ʻia.

Me nā ala pale, ʻo ka hopena mua o ka lāʻau lapaʻau ka like, i ka wā e hiki mai ana ke kau pono i nā hopena o ka pēpē a me ka hana ʻana i ke koko.

Pehea e hiki ai iaʻu ke hoʻololi i ka NovoNorm

No ka NovoNorm, ua koho ʻia nā mea hoʻohālikelike e like me ke ʻano o ka honua no ka helu ʻana i nā lāʻau lapaʻau ʻia ATS (hoʻonaninani, ka therapeutic a me ka papa helu kemu). ʻO ka repaglinide ma kāna hoʻopili e loaʻa ai nā lāʻau hou aku 2 - ʻo Repodiab a me Insvada.

E like me nā hōʻike a me ke ʻano o ka hoʻohana ʻana, like nā repaglinides:

  • Kahuʻi;
  • Baeta;
  • Victoza;
  • Lycosum;
  • Forsyga;
  • Saxenda;
  • Jardin
  • Invokana.

Amaril, Bagomet, Glibenclamide, Glibomet, Glyukofazh, Glurenorm, Glyclazid, Diabeton, Diaformin, Metformin, Maninil, Ongliza, Siofor, Yanumet, Yanuviya a me nā mea ʻē aʻe e kokoke ana i ka paeʻuʻāina 3 ATC code (ʻokoʻa he ʻano like ʻole nā ​​mea ʻike).

Ma ka ʻokoʻa ʻana o nā lāʻau lapaʻaka hypoglycemic hou, e hoʻomaʻamaʻa ʻole ana nā kauka iā lākou iho, a ʻaʻole hiki ke ʻae ʻia no nā poʻe maʻi maʻi e hoʻokolohua me nā lāʻau me ka ʻole o ka hoʻonaʻauao olakino. Hōʻike ʻia ka ʻike ma ka ʻatikala no ke ʻano laulā nui.

Nā Hōʻike Hoʻomaʻi

E pili ana i nā loiloi NovoNorm o nā kauka a me nā maʻi maʻi e kūpono mau. ʻO ka lāʻau lapaʻau e hoʻoili ʻia ma Tenemaka i ka hui ʻo NovoNordisk, kahi i mālama mua ʻia ai ka palekana o nā lāʻau lapaʻau.

Ignatenko Yu.A., 45 makahiki, Yekaterinburg. Ua maʻi wau i ka maʻi maʻamau ʻo ka maʻi 2 no nā makahiki he 5 i kēia manawa. Ua hoʻohui koʻu endocrinologist iaʻu i Novormin i ka hōʻike ʻana o nā hōʻike hou no ka hemoglobin glycated. Ua mālama wau i nā paila no 3 mau mahina i kēia manawa, ke mālama nei i ke kō, no laila, ʻaʻole wau e hoʻokolohua me nā lāʻau lapaʻau ʻē aʻe.

Maria Konstantinovna, 67 makahiki, Saratov. Ua hoʻohui pū lākou iā NovoNorm iaʻu, no ka mea, ua loaʻa nō iaʻu nā lāʻau ʻē aʻe (ua hoʻāʻo wau e ʻoi aku iā lākou) ʻaʻole hiki ke hoʻokō. Ke hoʻoikaika nei kuʻu mau niho, no laila makaʻu wau i nā lāʻau hou. Akā no kahi hapalua makahiki ʻaʻole wau i ʻike ʻole i nā hopena kūikawā kūikawā, ʻōlelo a ke kauka, he lāʻau lapaʻau kēia o nā ʻano momona o ʻEulopa, a ua kūpono ke kumukūʻai no ke kamaʻāina. E manaʻolana mākou no ka mea maikaʻi loa.

ʻO ke aʻo wanana e pili ana i ka hoʻokele ʻana i ka maʻi type 2 - ma ka hōʻike TV "Tablet" - ma kēia wikiō.

Pin
Send
Share
Send